Micro Imaging Technology, Inc.announced that, through its collaboration with Northern Michigan University (NMU), it has developed a testing protocol that allows for detection of pathogen species from liquid cultures. Dr. Josh S. Sharp, Ph.D., assistant professor at the NMU Department of Biology in Marquette, Michigan, is researching clinical applications of the MIT 1000 System, particularly the pathogens Staphylococcus aureus (S. aureus) and Methicillin Resistant S. aureus (MRSA).
According to MIT, it has developed and patented the MIT 1000, a stand-alone, rapid, optically-based, software driven system that can identify pathogenic bacteria and complete an identification test, after culturing, in three minutes (average) at the lowest cost per test over any other conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. It requires clean filtered water and a sample of the unknown bacteria.
Read the full article on the Canadian Business Journal website.
An inter-country meeting is taking place July 20-22 in Liberia on the topic of Ebola: Infection prevention and control recovery plans and implementation.
Monrovia is hosting a meeting of infection prevention and control (IPC) experts from the 3 Ebola-affected countries. The overall aim of the meeting is to share experiences on IPC practices, and water and sanitation hygiene, as well as to plan the recovery and implementation. Meetings such as this can ensure the ongoing IPC challenges can be addressed, given health system recovery and strengthening is dependent on this. This meeting comes at a critical time as the 3 countries have progressed significantly in the Ebola response but getting to zero cases is still paramount. A report will be made publicly available following the meeting.
You can find the latest Ebola information and updates on the World Health Organization website.
Cases of Ebola Virus Disease in the past 21 days. Source: World Health Organization
Researchers are questioning whether the stool transplants could work for bowel diseases other than C. difficile, such as ulcerative colitis. However, the first trials looking at whether ulcerative colitis could be treated with an infusion of a healthy person’s stool produced confusing results…
Read the full article on the Hamilton Spectator website.
From the Montreal Gazette:
“Acute Lyme disease, of course, is very real. It is an infection caused by the bacteria Borrelia burgdorferi and gets spread to humans via bites from ticks of the Ixodes species. Adult ticks prefer to feed on white-tailed deer, but if an unassuming human happens by, they will happily latch on to the skin and feed on their host’s blood. The tick passes the bacteria to the human, who then gets sick. Fortunately, the infection can be cured with a two- to four-week course of antibiotics.
Post Lyme disease syndrome, sometimes called chronic Lyme disease, is a completely different problem. It is usually used to describe the headache, fatigue and joint pain that can persist for months after an infection is eradicated. The exact cause of these symptoms is unclear, although some of it may be residual inflammation after the infection.”
Read the full article here.